PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer Frontiers in pharmacology 8, 561, 2017 | 1699 | 2017 |
Phage display derived monoclonal antibodies: from bench to bedside MA Alfaleh, HO Alsaab, AB Mahmoud, AA Alkayyal, ML Jones, SM Mahler, ... Frontiers in immunology 11, 1986, 2020 | 232 | 2020 |
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery AK Sharma, A Gothwal, P Kesharwani, H Alsaab, AK Iyer, U Gupta Drug Discovery Today 22 (2), 314-326, 2017 | 230 | 2017 |
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy JM Wickens, HO Alsaab, P Kesharwani, K Bhise, MCIM Amin, RK Tekade, ... Drug discovery today 22 (4), 665-680, 2017 | 180 | 2017 |
Advances in antibody–drug conjugates: a new era of targeted cancer therapy S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer Drug Discovery Today 22 (10), 1547-1556, 2017 | 169 | 2017 |
Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment S Sau, HO Alsaab, K Bhise, R Alzhrani, G Nabil, AK Iyer Journal of Controlled Release 274, 24-34, 2018 | 152 | 2018 |
Progress in clinical trials of photodynamic therapy for solid tumors and the role of nanomedicine HO Alsaab, MS Alghamdi, AS Alotaibi, R Alzhrani, F Alwuthaynani, ... Cancers 12 (10), 2793, 2020 | 112 | 2020 |
Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers D Luong, P Kesharwani, HO Alsaab, S Sau, S Padhye, FH Sarkar, AK Iyer Colloids and Surfaces B: Biointerfaces 157, 490-502, 2017 | 97 | 2017 |
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017; 8: 561 HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer Frontiers Media SA DOI 10, 2017 | 73 | 2017 |
Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages HO Alsaab, S Sau, RM Alzhrani, VT Cheriyan, LA Polin, U Vaishampayan, ... Biomaterials 183, 280-294, 2018 | 68 | 2018 |
CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer Z Wang, S Sau, HO Alsaab, AK Iyer Nanomedicine: nanotechnology, biology and medicine 14 (4), 1441-1454, 2018 | 64 | 2018 |
Nanomedicine for cancer diagnosis and therapy: Advancement, success and structure–activity relationship K Bhise, S Sau, H Alsaab, SK Kashaw, RK Tekade, AK Iyer Therapeutic delivery 8 (11), 1003-1018, 2017 | 63 | 2017 |
PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases HO Alsaab, FD Alharbi, AS Alhibs, NB Alanazi, BY Alshehri, MA Saleh, ... Pharmaceutics 14 (12), 2728, 2022 | 54 | 2022 |
PDL-1 antibody drug conjugate for selective chemo-guided immune modulation of cancer S Sau, A Petrovici, HO Alsaab, K Bhise, AK Iyer Cancers 11 (2), 232, 2019 | 54 | 2019 |
Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma S Yousef, HO Alsaab, S Sau, AK Iyer Heliyon 4 (12), 2018 | 48 | 2018 |
The psychological impact of COVID-19 on healthcare workers in Saudi Arabia: a year later into the pandemic AH Almalki, MS Alzahrani, FS Alshehri, A Alharbi, SF Alkhudaydi, ... Frontiers in Psychiatry 12, 797545, 2021 | 46 | 2021 |
Organogels in drug delivery: a special emphasis on pluronic lecithin organogels H Alsaab, SP Bonam, D Bahl, P Chowdhury, K Alexander, SHS Boddu Journal of Pharmacy & Pharmaceutical Sciences 19 (2), 252-273, 2016 | 45 | 2016 |
Folate decorated nanomicelles loaded with a potent curcumin analogue for targeting retinoblastoma H Alsaab, RM Alzhrani, P Kesharwani, S Sau, SHS Boddu, AK Iyer Pharmaceutics 9 (2), 15, 2017 | 44 | 2017 |
Designing a novel visible-light-driven heterostructure Ni–ZnO/SgC 3 N 4 photocatalyst for coloured pollutant degradation A Bahadur, S Iqbal, HO Alsaab, NS Awwad, HA Ibrahium RSC advances 11 (58), 36518-36527, 2021 | 41 | 2021 |
The possible relationship between the abuse of tobacco, opioid, or alcohol with COVID-19 YS Althobaiti, MA Alzahrani, NA Alsharif, NS Alrobaie, HO Alsaab, ... Healthcare 9 (1), 2, 2020 | 40 | 2020 |